Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
LNSR
#3130
LENSAR, Inc. Common Stock
11.9
7
-0.66%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-0.66%
Changement Mensuel
-3.86%
Evolution sur 6 mois
-1.89%
Changement Annuel
+7.55%
Clôture Précédente
12.0
5
Open
11.9
7
Bid
Ask
Low
11.9
7
High
11.9
7
Volume
17
Marchés
Actions des Marchés US
Soins de Santé
LNSR
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Nouvelles
La clôture de l’accord LENSAR-Alcon repoussée au premier semestre 2026
LENSAR-Alcon deal closing pushed to first half of 2026
Lensar: Timing And Arbitrage Considerations In Alcon's Acquisition Bid (NASDAQ:LNSR)
Le BPA de LENSAR a manqué les attentes de 0,26$, le CA en dessous des prévisions
LENSAR earnings missed by $0.26, revenue fell short of estimates
LENSAR earnings missed by $0.08, revenue fell short of estimates
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019 - Alcon (NYSE:ALC)
Alcon: A Clear Vision, But Fully Valued (NYSE:ALC)
Alcon Eyes Surgical Edge With LENSAR Buyout: Details - LENSAR (NASDAQ:LNSR), Alcon (NYSE:ALC)
LENSAR stock surges 23.7% as Q4 revenue beats estimates